Claudine Q. Homolash to speak in San Diego on Risperdal
Claudine Q. Homolash, Esquire, and other experienced trial lawyers, will be speaking at the AAJ Education on March 25–26 at the Loews Coronado Bay Resort in San Diego at the Plaintiff-Only Pharmaceuticals and Medical Device Litigation Update Seminar.
The full-day seminar opens on March 26 with the very latest in litigating testosterone therapy. Faculty will cover the science behind the drug, general theories of liability, general and specific causation, case criteria, and the current status of litigation. AAJ’s Testosterone Therapy Litigation Group will hold a members-only business meeting at the conclusion of the seminar.
A faculty of experienced trial lawyers will provide litigation updates and trial strategies on a variety of pharmaceuticals and medical devices, including Risperdal, Lipitor, Actos, Pradaxa, DePuy ASR Settlement, St. Jude’s Defibrillator Device Leads, Acetaminophen/Tylenol, Biomet, and more. Ms. Homolash will be speaking on the drug Risperdal.
View the full agenda, faculty biographies, and register online at www.justice.org/JPMLmarch. Call AAJ Education at 800.622.1791 or 202.965.3500, ext. 8612 with any questions.